Longitudinal Study of Mitochondrial Hepatopathies (MITOHEP)
Jean Molleston, MD
Primary Investigator
Brief description of study
The purpose of this study is to help researchers learn more about these rare liver diseases that occur in infants, children, and young adults.
Detailed description of study
The purpose of this study is to help researchers learn more about these rare liver diseases that occur in infants, children, and young adults.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Liver Disease
-
Age: - 18 Years
-
Gender: All
Inclusion Criteria
Children ages 0-18yo with suspected or documented hepatic respiratory chain or fatty acid oxidation defects
Children with suspected mitochondrial disease and evidence of acute or chronic liver disease and evidence of at least one of the following: extrahepatic disease, lactic acidosis, hypoglycemia, abnormal acylcarnitine profile, or documented biochemical enzymatic or genetic diagnosis.
Children with suspected mitochondrial disease who have undergone liver transplantation and who have evidence of at least one of the following: extrahepatic disease, lactic acidosis, hypoglycemia, abnormal acylcarnitine profile, or documented biochemical enyzmatic or genetic diagnosis.
Children with suspected mitochondrial liver disease who do not yet meet above criteria.
Exclusion Criteria
Inability to comply with the longitudinal follow-up
Failure of family to sign consent/assent or HIPAA authorization form
Known medium Chain Acyl CoA Dehydrogenase Deficiency
Other known causes of liver disease
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
